GeneDx (WGS) Insider Trading & Ownership $129.19 +2.94 (+2.33%) Closing price 04:00 PM EasternExtended Trading$127.50 -1.69 (-1.31%) As of 06:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock GeneDx (NASDAQ:WGS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage29.60%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$5.60MNumber OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$168.90M Get WGS Insider Trade Alerts Want to know when executives and insiders are buying or selling GeneDx stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. WGS Insider Buying and Selling by Quarter GeneDx Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/22/2025Casdin Capital, LlcDirectorSell500,000$120.90$60,450,000.00 7/29/2025Katherine StuelandCEOSell2,154$105.31$226,837.74 7/29/2025Kevin FeeleyCFOSell388$105.31$40,860.28 7/9/2025Katherine StuelandCEOSell3,220$93.00$299,460.00 7/9/2025Kevin FeeleyCFOSell5,278$93.00$490,854.00 7/1/2025Katherine StuelandCEOSell9,657$90.94$878,207.58 7/1/2025Kevin FeeleyCFOSell1,344$91.12$122,465.28 6/2/2025Kevin FeeleyCFOSell370$71.26$26,366.20 5/8/2025Keith A MeisterDirectorBuy100,000$56.01$5,601,000.00 4/29/2025Katherine StuelandCEOSell2,154$113.09$243,595.86 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/29/2025Kevin FeeleyCFOSell388$113.09$43,878.92 4/9/2025Katherine StuelandCEOSell46,594$89.62$4,175,754.28 4/9/2025Kevin FeeleyCFOSell15,516$92.18$1,430,264.88 3/26/2025Katherine StuelandCEOSell46,551$95.62$4,451,206.62 3/26/2025Kevin FeeleyCFOSell8,746$95.61$836,205.06 3/17/2025Katherine StuelandCEOSell10,559$96.71$1,021,160.89 3/17/2025Kevin FeeleyCFOSell3,749$96.71$362,565.79 3/13/2025Katherine StuelandCEOSell1,078$89.44$96,416.32 3/13/2025Kevin FeeleyCFOSell402$90.05$36,200.10 3/10/2025Katherine StuelandCEOSell2,731$94.73$258,707.63 3/10/2025Kevin FeeleyCFOSell922$94.72$87,331.84 1/29/2025Katherine StuelandCEOSell1,657$78.48$130,041.36 1/29/2025Kevin FeeleyCFOSell275$78.48$21,582.00 1/7/2025Katherine StuelandCEOSell51,420$94.48$4,858,161.60 1/7/2025Kevin FeeleyCFOSell35,506$93.82$3,331,172.92 1/2/2025Katherine StuelandCEOSell18,006$78.18$1,407,709.08 1/2/2025Kevin FeeleyCFOSell1,430$76.04$108,737.20 12/16/2024Katherine StuelandCEOSell10,501$76.75$805,951.75 12/16/2024Kevin FeeleyCFOSell3,728$76.75$286,124.00 12/9/2024Katherine StuelandCEOSell3,661$76.37$279,590.57 12/9/2024Kevin FeeleyCFOSell1,137$76.37$86,832.69 12/2/2024Kevin FeeleyCFOSell263$78.39$20,616.57 11/21/2024Kevin FeeleyCFOSell12,019$73.76$886,521.44 11/19/2024Jason RyanDirectorSell31,510$71.28$2,246,032.80 11/18/2024Katherine StuelandCEOSell22,307$70.34$1,569,074.38 11/18/2024School Of Medicine At Mo IcahnMajor ShareholderSell126,782$70.78$8,973,629.96 11/15/2024Katherine StuelandCEOSell23,108$70.48$1,628,651.84 11/15/2024School Of Medicine At Mo IcahnMajor ShareholderSell20,359$69.78$1,420,651.02 10/31/2024School Of Medicine At Mo IcahnMajor ShareholderSell865,800$75.00$64,935,000.00 10/29/2024Katherine StuelandCEOSell2,154$66.60$143,456.40 INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad)Right now, we’re witnessing a monumental shift in the world.Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia.10/29/2024Kevin FeeleyCFOSell274$66.60$18,248.40 9/9/2024Katherine StuelandCEOSell3,639$33.33$121,287.87 9/9/2024Kevin FeeleyCFOSell895$33.33$29,830.35 9/3/2024Kevin FeeleyCFOSell262$31.71$8,308.02 (Data available from 1/1/2013 forward) WGS Insider Trading Activity - Frequently Asked Questions Who is on GeneDx's Insider Roster? The list of insiders at GeneDx includes Casdin Capital, Llc, Jason Ryan, Kareem Saad, Karen Ann White, Katherine Stueland, Keith A Meister, Kevin Feeley, Opko Health, Inc., Richard C Pfenniger Jr, and School Of Medicine At Mo Icahn. Learn more on insiders at WGS. What percentage of GeneDx stock is owned by insiders? 29.60% of GeneDx stock is owned by insiders. Learn more on WGS's insider holdings. Which GeneDx insiders have been buying company stock? The following insiders have purchased WGS shares in the last 24 months: Casdin Capital, Llc ($4,121,270.44), Jason Ryan ($72,062.34), Keith A Meister ($5,601,000.00), and Richard C Pfenniger Jr ($14,900.00). How much insider buying is happening at GeneDx? Insiders have purchased a total of 382,546 WGS shares in the last 24 months for a total of $9,809,232.78 bought. Which GeneDx insiders have been selling company stock? The following insiders have sold WGS shares in the last 24 months: Casdin Capital, Llc ($60,450,000.00), Jason Ryan ($2,246,166.78), Kareem Saad ($37,181.02), Katherine Stueland ($23,194,010.57), Kevin Feeley ($8,451,611.99), Opko Health, Inc. ($23,874,134.15), and School Of Medicine At Mo Icahn ($75,329,280.98). How much insider selling is happening at GeneDx? Insiders have sold a total of 2,709,700 GeneDx shares in the last 24 months for a total of $193,582,385.49 sold. GeneDx Key ExecutivesMs. Katherine A. Stueland (Age 48)President, CEO & Director Compensation: $745.91k9 recent tradesMr. Kevin Feeley (Age 43)Chief Financial Officer Compensation: $488.19k10 recent tradesMs. Karen PonchnerSenior VP & Head of OperationsMr. Eric Olivares Ph.D.Chief Product & Technology OfficerMr. Devin K. Schaffer J.D.M.B.A., General CounselMr. Paul Kruszka M.D.Chief Medical OfficerMs. Melanie DuquetteChief Growth OfficerSabrina DunbarChief of Staff More Insider Trading Tools from MarketBeat Related Companies HIMS Insider Buying GH Insider Buying RDNT Insider Buying OPCH Insider Buying SHC Insider Buying BTSG Insider Buying SGRY Insider Buying PRVA Insider Buying VCYT Insider Buying ADUS Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Reynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say BuyStrategy Insiders Buy In While Analysts Predict Big Upside This page (NASDAQ:WGS) was last updated on 8/27/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GeneDx Holdings Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share GeneDx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access